A COS is a minimum set of outcomes of specific importance that should be measured and reported in all clinical trials for a specific condition. SBU is, as a producer of systematic reviews, one stakeholder of clinical trials. As such, SBU has been involved as a participant in the development of COS. SBU endorses the usage of robustly developed COS in clinical trials and in systematic reviews.

свернуть